EXPLAINER

Steroid nasal spray vs antihistamine pill for allergies: which wins?

For hay fever and year-round allergy, the pill most people reach for is not the strongest option. A meta-analysis found steroid nasal sprays beat oral antihistamines across nasal symptoms — most of all a blocked nose.

How much more the steroid spray relieved each symptom than antihistamine tabletsNasal blockage: 0.63standardised mean difference (favouring the spray); Nasal discharge: 0.5standardised mean difference (favouring the spray); Sneezing: 0.49standardised mean difference (favouring the spray); Nasal itch: 0.38standardised mean difference (favouring the spray); Post-nasal drip: 0.24standardised mean difference (favouring the spray)0standardised mean difference (favouring the spray)0.4standardised mean difference (favouring the spray)0.8standardised mean difference (favouring the spray)Nasal blockage0.63standardised mean difference (favouring the spray)Nasal discharge0.5standardised mean difference (favouring the spray)Sneezing0.49standardised mean difference (favouring the spray)Nasal itch0.38standardised mean difference (favouring the spray)Post-nasal drip0.24standardised mean difference (favouring the spray)
How much more the steroid spray relieved each symptom than antihistamine tablets
GroupValue (standardised mean difference (favouring the spray))
Nasal blockage0.63 (0.53 to 0.73)
Nasal discharge0.5 (0.4 to 0.6)
Sneezing0.49 (0.39 to 0.59)
Nasal itch0.38 (0.21 to 0.49)
Post-nasal drip0.24 (0.06 to 0.42)
How much more the steroid spray relieved each symptom than antihistamine tablets Pooled from 16 randomised trials in 2,267 people with allergic rhinitis; bars show the magnitude of the difference favouring intranasal corticosteroids, with 95% confidence intervals. Source: BMJ

Faced with a sneezing, streaming, blocked-up nose from hay fever or a year-round allergy, most people reach for an antihistamine tablet. It is the reflex the whole pharmacy aisle is built around. But if the goal is to control nasal symptoms — and especially the stuffed-up feeling — the tablet is not the strongest tool available. Head-to-head, a steroid nasal spray does more, and the guidelines agree.

What the head-to-head evidence shows

The clearest comparison is a BMJ meta-analysis that pooled 16 randomised controlled trials in 2,267 people with allergic rhinitis, pitting intranasal corticosteroid sprays directly against oral antihistamine tablets [s1]. Across the board, the sprays produced significantly greater relief of nasal symptoms [s1]. The advantage was largest for the symptom antihistamines struggle with most — nasal blockage, where the spray beat the pill with a standardised mean difference of −0.63 (95% CI −0.73 to −0.53) [s1]. It also won for nasal discharge (−0.50), sneezing (−0.49), nasal itch (−0.38) and post-nasal drip (−0.24, 95% CI −0.42 to −0.06), as well as total nasal symptoms (−0.42) [s1]. On a global rating, people on antihistamines were far more likely to deteriorate (odds ratio 0.26, 95% CI 0.08 to 0.8 favouring the spray) [s1]. The review's conclusion was direct: the evidence, with data on safety and cost, supports intranasal corticosteroids over oral antihistamines as first-line treatment for allergic rhinitis [s1].

Where the pill holds its own

The spray does not win everything. In the same analysis, there was no significant difference between the two treatments for eye symptoms [s1] — the itchy, watering eyes of hay fever, which a nose spray is poorly placed to reach and an oral antihistamine (which circulates throughout the body) can help. That is the practical case for keeping an antihistamine in the mix: for someone whose main complaint is their eyes, or who wants something taken once in the morning rather than sprayed into the nose, the tablet is reasonable. The point is not that antihistamines are useless — they are effective and safe — but that for the nose itself, they are the weaker of the two.

Why the guidelines line up behind the spray

This is not a lone study. The international Allergic Rhinitis and its Impact on Asthma (ARIA) guideline, in its 2016 revision, positions intranasal corticosteroids as a mainstay of allergic-rhinitis treatment and weighs them against and alongside oral antihistamines in its recommendations [s2]. Consumer guidance reflects the same hierarchy: MedlinePlus lists nasal corticosteroid sprays among the most effective treatments for allergic rhinitis, alongside antihistamines and avoiding the trigger where possible [s3].

How to actually use a steroid spray

The catch with steroid sprays is that they are misused in a way that quietly wastes their advantage. Unlike an antihistamine, which works within hours, a nasal steroid builds its effect over days of regular use — so it works best taken every day through the allergy season, ideally started before or as symptoms begin, rather than grabbed only on the worst days [s2][s3]. Technique matters too: aiming the spray slightly outward, away from the central nasal septum, reduces irritation and the occasional nosebleed that puts people off. Used as a daily preventive rather than a rescue puff, it is doing the job the trials measured. A common disappointment is stopping after two or three days because "it did not work" — which, for a medicine that needs a week of steady use to reach full effect, judges it before it has had the chance the trials gave it. Many people who conclude the spray failed had in fact never used it the way the evidence was generated.

The bottom line, and when to see a doctor

For controlling the nasal symptoms of hay fever and year-round allergy, a steroid nasal spray used consistently outperforms an oral antihistamine, most decisively for a blocked nose [s1][s2]. An antihistamine remains a sensible addition for eye symptoms or as a convenient extra [s1]. Both are available without prescription in many places, but see a doctor if symptoms are severe or year-round and not controlled, if there is facial pain, a one-sided blockage, or wheezing and breathlessness suggesting the allergy is affecting the chest, or before starting regular treatment in a child. For the related question of what triggers the drip these treat, see post-nasal drip. None of this is medical advice.

Sources

Sources

  1. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials — BMJ , December 12, 1998
  2. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision — Journal of Allergy and Clinical Immunology , October 1, 2017
  3. Allergic rhinitis: MedlinePlus Medical Encyclopedia — MedlinePlus / US National Library of Medicine

More on

Related coverage